Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
SPECIALISED THERAPEUTICS AUSTRALIA PTY LTD
{{company.company_channel.channel_name}}
Media Room
Latest
Photos
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
Specialised Therapeutics signs exclusive license agreement with CanariaBio for new ovarian cancer therapy
2023-10-13 03:00
World Orphan Drug Alliance Welcomes Specialised Therapeutics
2023-09-08 04:00
Specialised Therapeutics acquires commercialisation rights to new oral MND therapy
2023-08-28 04:00
GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME
2023-07-31 15:00
LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma
2023-06-28 04:00
NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE
2023-05-08 04:00
Specialised Therapeutics signs partnership agreement with Akeso Inc. and CTTQ-Akeso to commercialise new anti-PD1 antibody in Australia and Southeast Asia
2023-04-12 06:00
GLOBAL SARCOMA THERAPY NOW APPROVED FOR NEW ZEALAND PATIENTS
2023-02-17 03:00
NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS
2023-01-20 02:00
New treatment for rare cancer cholangiocarcinoma approved in Australia
2022-09-15 21:00
NEW EARLY BREAST CANCER DRUG TO REDUCE RISK OF RECURRENCE OR DEATH NOW AVAILABLE IN THE PHILIPPINES
2022-07-08 09:28
Specialised Therapeutics Enters into a New Supply and Distribution Agreement with Incyte to Launch Two New Cancer Therapies, Tafasitamab and Pemigatinib, in Australia, New Zealand and Singapore
2021-10-22 09:00
New Therapy to Treat Advanced Small Cell Lung Cancer ZEPZELCA® (lurbinectedin) Approved in Singapore
2021-09-22 14:30
New Therapy to Treat Advanced Small Cell Lung Cancer Approved for Australian Patients
2021-09-14 18:57
New Drug for Gastrointestinal Stromal Tumours (GIST) to be Launched in Australia, New Zealand and South East Asia Following Distribution Agreement
2020-11-06 05:30
New Early Breast Cancer Drug Now Approved in Malaysia
2020-07-17 06:16
New Small Cell Lung Cancer Drug Accepted for TGA Evaluation Under Project Orbis
2020-06-03 14:30
New Early Breast Cancer Drug Available Now In Singapore
2020-04-23 12:33
Specialised Therapeutics Signs Exclusive Deal for New Haematology Drug
2019-12-18 22:00
New Early Breast Cancer Drug Approved by Singapore Health Sciences Authority
2019-12-03 05:30
1
2